[1]陈景云,赵永成.辐射致癌危险模型及人群危险转移研究概况[J].国际放射医学核医学杂志,2014,38(5):341-346.[doi:10.3760/cma.j.issn.1673-4114.2014.05.015]
 Chen Jing-yun,Zhao Yong-cheng.Research advances on risk models of radiogenic cancer and risk transfer models between population[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):341-346.[doi:10.3760/cma.j.issn.1673-4114.2014.05.015]
点击复制

辐射致癌危险模型及人群危险转移研究概况(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
38
期数:
2014年第5期
页码:
341-346
栏目:
出版日期:
2014-09-25

文章信息/Info

Title:
Research advances on risk models of radiogenic cancer and risk transfer models between population
作者:
陈景云 赵永成
中国医学科学院放射医学研究所, 天津市放射医学核医学重点实验室, 天津, 300192
Author(s):
Chen Jing-yun Zhao Yong-cheng
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Tianjin 300192, China
关键词:
肿瘤辐射性模型统计学病因概率人群危险转移
Keywords:
Neoplasmsradiation-inducedModelsstatisticalProbability of causationRisk transfer between population
DOI:
10.3760/cma.j.issn.1673-4114.2014.05.015
摘要:
对日本原子弹爆炸幸存者队列的流行病学研究,是各国进行辐射危害评价及赔偿的主要依据。依据流行病学数据建立模型,定量计算辐射危险,使该结果的应用更加明确。近年来随着日本原子弹爆炸幸存者队列数据资料的进一步搜集、方法学的不断完善,模型的研究也取得了新的进展。该文对迄今为止各个主要致力于辐射致癌研究的机构给出的辐射致癌模型及人群危险转移进行综述,简要介绍建立模型及转移时考虑的因素,以期为我国辐射致癌赔偿相关应用提供参照。
Abstract:
The epidemiology study on Japanese Life Span Study Cohort is the main basis of radiation risk assessment and compensation for many countries. The models based on epidemiology data can calculate risk quantificationally, and provide explicit result for application. Recent years, with the data collection of Japanese Life Span Study Cohort and advancement of methodology, studies on risk model have made a great progress. The paper summarizes the models of radiogenic cancer and risk transfer models between populations which are established by the main institutions of radiation related cancer research, and briefly introduces the main considerations when establishes the model and transfers the risk between populations. In order to provide reference for the application of carcinogenic compensation related to radiation in china.

参考文献/References:

[1] Annals of the ICRP.ICRP publication 26:1977 recommendations of the International Commission on Radiological Protection[R].New York:Pergamon Press,1977:21.
[2] Mummery PW,Alderson BA.The BNFL Compensation Agreement for radiation linked diseases[J].J Radiol Prot,1989,9(3):179-184.
[3] 孙世荃.辐射致癌病因概率的赔偿界限[J].中华放射医学与防护杂志,1980,9(3):150-154.
[4] Charles M.UNSCEAR Report 2000:sources and effects of ionizing radiation[J].J Radiol Prot,2001,21(1):83-86.
[5] National Council on Radiation Protection and Measurements.NCRP Report No.126,Uncertainties in fatal cancer risk estimates used in radiation protection[R].Bethesda:National Council on Radiation Protection and Measurements Press,1997:40-50.
[6] Fabrikant JI,于水.BEIRⅣ报告:氡与肺癌[J].国外医学放射医学核医学分册,1991,15(4):161-164.
[7] 孙世荃.BEIRⅣ估计氡致肺癌危险的 TSE-RR 模型和氡致肺癌危险度[J].辐射防护,1991,11(4):255-260.
[8] Committee on the Biological Effects of Ionizing Radiation(BEIRV),Commission on Life Sciences,Division on Earth and Life Studies,et al.Health effects of exposure to low levels of ionizing radiation:BEIR V[R].Washington DC:National Academy of Sciences,1990:161-241.
[9] 孙世荃.BEIR V 辐射致癌危险系数估算的方法和结果[J].辐射防护,1991,11(5):394-398,393.
[10] 孙世荃.人类辐射危害评价[M].北京:原子能出版社,1996:149-276.
[11] Committee on Health Risks of Exposure to Radon(BEIR VI),Com-mission on Life Sciences,Division on Earth and Life Studies,et al.Health effects of exposure to radon:BEIR VI[R].Washington DC:National Academy Press,1999:1-516.
[12] 童建.氡致肺癌的危险度评价模型[J].中华劳动卫生职业病杂志,2007,25(6):372-374.
[13] Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation,Board on Radiation Effects Research(BRER),Division on Earth and Life Studies(DELS),et al.Health Risks from Exposure to Low Levels of Ionizing Radiation:BEIR Ⅶ Phase2[R].Washington DC:National Academies Press,2006.
[14] Preston DL,Mattsson A,Holmberg E,et al.Radiation effects on breast cancer risk:a pooled analysis of eight cohorts[J].Radiat Res,2002,158(2):220-235.
[15] International Commission on Radiological Protection.1990 Recommendations of the International Commission on Radiological Protection[R].Ann ICRP,1991,21(1-3):1-201.
[16] International Commission on Radiological Protection.The 2007 Recommendations of the International Commission on RadiologicalProtection.ICRP Publication 103[R].Ann ICRP,2007,37(2-4):1-332.
[17] International Commission on Radiological Protection.The Biological Basis for Dose Limitation in the skin.A report of a Task Group of Committee 1 of the International Commission on Radiological Protection[R].Ann ICRP,1991,22(2):1-104.
[18] Preston DL,Kusumi S,Tomonaga M,et al.Cancer incidence in atomic bomb survivors.Part Ⅲ:Leukemia,lymphoma and multiple myeloma,1950-1987[J].Radiat Res,1997,137(2S):S68-97.
[19] United Nations Scientific Committee on the Effects of Atomic Radiation.Effects of ionizing radiation:UNSCEAR 2006 Report to the General Assembly,with scientific annexes[R].New York:United Nations Publications,2009:17-120.
[20] 美国国立卫生研究院. 放射流行病学表-美国国立卫生研究院特别工作组报告(NIH 85-2784)[M].北京放射医学研究所,译.北京:中华人民共和国卫生部卫生防疫司,1987:37-181.
[21] Land CE,Gilbert E,Smith JM,et al.Report of the NCI-CDC Working Group to revise the 1985 NIH radioepidemiological tables.NIH Publication DHHS Publ No.03-5387[R].Bethesda:National Institute of Health,2003:5-65.
[22] 宁静.放射性肿瘤病因概率及其计算方法研究[D].北京:中国人民解放军军事医学科学院,2009.
[23] 孙志娟.中国X射线工作者辐射致癌危险估算[D].北京:北京协和医学院,2011.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
 He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
 Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
 Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
 Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
 zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
 Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
 Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
 Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
 Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
 Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[11]王宏,刘强,杜丽清,等.DNA修复基因hOGG1的寡核苷酸多态性与癌症遗传易感性的关系[J].国际放射医学核医学杂志,2012,36(2):101.[doi:10.3760/cma.j.issn.1673-4114.2012.02.011]
 WANG Hong,LIU Qiang,DU Li-qing,et al.Single nucleotide polymorphism of DNA repair gene hOGG1 and genetic susceptibility of cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):101.[doi:10.3760/cma.j.issn.1673-4114.2012.02.011]
[12]石大伟,赵永成.电离辐射诱导的DNA甲基化模式改变及其在辐射致癌机制研究中的意义[J].国际放射医学核医学杂志,2006,30(4):240.
 SHI Da-wei,ZHAO Yong-cheng.Radiation-induced DNA methylation profile changes and its impact on mechanisms of radiation carcinogenesis[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):240.

备注/Memo

备注/Memo:
收稿日期:2014-04-21。
基金项目:国家卫生和计划生育委员会标准项目(20130702);协和青年基金(33320140032)
通讯作者:赵永成(Email:zhaoyc60@irm-cams.ac.cn)
更新日期/Last Update: 1900-01-01